Abstract Library

#4658 The nutritional status worsens over 5 years in patients with gastroenteropancreatic neuroendocrine tumours on treatment with somatostatin analogues

Introduction: Malnutrition is common in patients with gastroenteropancreatic neuroendocrine tumours (GEP-NETs) treated with monthly somatostatin analogues (SSAs). Ideally all malnourished patients are offered nutritional support. However, clinical guidelines and data on the development and progression of malnutrition is lacking.

Conference:

Presenting Author: Clement D

Authors: Soran V, Srirajaskanthan R, Cananea E, Martin W, Minott S,

Keywords: gastroenteropancreatic neuroendocrine tumour, malnutrition, somatostatin analogue,

#4479 Bilateral adrenal masses associated with arterial hypertension with rare and unexpected definitive histopathological diagnosis: A case report

Introduction: During the clinical approach of bilateral adrenal masses, some imaging, biochemical and clinical guidelines are established to guide the diagnosis; however, only the histopathological result is what definitively establishes the diagnosis.

Conference:

Presenting Author: Rueda M

Authors: Rueda M, Cuellar A, Tapiero-Garcia M,

Keywords: adrenal gland, adrenal mass, Cystic lymphangioma, endothelial cyst, systemic arterial hypertension,

#4003 Neuroendocrine differentiation in gastric cancer: Epidemiological insights and therapeutic implications

Introduction: Gastric cancer (GC) with neuroendocrine differentiation (NED) represents a significant yet understudied subset, accounting for 10-40% of cases. The absence of tailored clinical guidelines highlights the urgent need for specialized treatment approaches.

Conference:

Presenting Author:

Authors: Huang Z, Wei J, Shen Y, Zhang J,

Keywords: Neuroendocrine Differentiation, Epidemiological, Treatment, Surufatinib,

#3216 Survey for neuroendocrine tumors’ standard of care - A multidisciplinary pilot study in Spanish specialists

Introduction: The standard of care for the treatment of neuroendocrine tumors (NETs) seems to have shifted over the last few years towards a multidisciplinary approach. In Spain, there is a lack of real-world data related to NET management in Medical NETs Specialist population.

Conference: 18th Annual ENETS Concerence (2021)

Presenting Author:

Authors: Sampedro-Núñez M, Muñoz de Nova J, Vázquez G, Hernando J, Triviño E,

Keywords: online survey, patient care, clinical guidelines, research, training,

#3054 Nutritional Status and Considerations for Patients Diagnosed with a Gastroenteropancreatic Neuroendocrine Tumour: Nutrition in NETs Study

Introduction: Gastroenteropancreatic neuroendocrine tumours (GEP NET) can adversely affect nutritional status. Cross-sectional studies report up to 25% of GEP NET patients are malnourished and dietary change may be prevalent. Nevertheless, clinical guidelines lack advice on nutrition management.

Conference: 17th Annual ENETSConcerence (2020)

Presenting Author: Laing E

Authors: Laing E, Kiss N, Michael M, Krishnasamy M, Gough K,

Keywords: neuroendocrine, nutrition, malnutrition, weight change, symptoms,